Goserelin--depot preparation of LHRH analogue used in the treatment of endometriosis
Monthly subcutaneous goserelin depot injections for six months effectively desensitized the pituitary, induced hypo-oestrogenism, and relieved endometriosis symptoms by reducing disease deposits.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (5)
- Differentialdiagnose und Behandlungsstrategien bei Endometriose: Was tun - wann? 2003
- Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel) 1997
- Tratamiento endocrinológico de la endometriosis 1997
- Hormone treatment of endometriosis: the estrogen threshold hypothesis 1992
- GnRH analogues in the treatment of endometriosis — rationale and efficacy 1991
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:38.374512+00:00